Back
MiMedx Group, Inc. 10K Form
Sell
48
MDXG
MiMedx Group, Inc.
Last Price:
$6.93
Seasonality Move:
8.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MDXG News And Ratings
See the #1 stock for the next 7 days that we like better than MDXG
MDXG Financial Statistics
Sales & Book Value
| Annual Sales: | $348.9M |
|---|---|
| Cash Flow: | $29.1M |
| Price / Cash Flow: | 15.26 |
| Annual Sales: | $1.61 |
| Price / Book: | 4.3 |
Profitability
| EPS (TTM): | 0.27300 |
|---|---|
| Net Income (TTM): | $40.8M |
| Gross Margin: | $287.2M |
| Return on Equity: | 19.77% |
| Return on Assets: | 14.7% |
MiMedx Group, Inc. Earnings Forecast
Key MiMedx Group, Inc. Financial Ratios
-
The Gross Profit Margin over the past 18 years for MDXG is 82.31%.
-
The Selling, General & Administrative Expenses for MDXG have been equal to 64.52% of Gross Profit Margin.
-
The Research & Development expenses have been 3.44% of Revenue.
-
The Interest Expense is 6.04% of Operating Income.
-
The Net Earning history of MDXG is 12.04% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 11 years.
MiMedx Group, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MDXG |
| CUSIP: | 602496 |
| Website: | mimedx.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 4.41 |
| Quick Ratio: | 3.91 |
Price-to-Earnings
| Trailing P/E Ratio: | 24.35 |
|---|---|
| Forward P/E Ratio: | 28.29 |
MDXG Technical Analysis vs Fundamental Analysis
Sell
48
MiMedx Group, Inc. (MDXG)
is a Sell
Is MiMedx Group, Inc. a Buy or a Sell?
-
MiMedx Group, Inc. stock is rated a SellThe current MiMedx Group, Inc. [MDXG] share price is $6.93. The Score for MDXG is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.